NEBGH Members only, NEBGH Policy Watch, Webinar

The First 100 Days of the Second Trump Administration: Health Care and Benefits Implications for Employers

Not a member and interested in attending? Contact Emily Commer!


Join us for a discussion with Washington, DC, insiders on the key health policy and human resources (HR) benefits developments from the first 100 days of the new administration.

Presenters will cover key executive orders and other administrative decisions and their impact on health care and employee benefits. They will also review potential shifts in Medicaid, Social Security, and government spending. This deep dive will explore the evolving landscape of HR benefits, including gender-affirming care, women’s health post-Dobbs, and the latest actions on in vitro fertilization, as well as diversity, equity, and inclusion initiatives.

Don’t miss this essential update for employers and HR professionals navigating the changing policy environment.

Speakers

Rachel Snyder Good

Strategic Counsel
Epstein Becker Green

Attorney Rachel Snyder Good draws on her 11 years of legislative experience, as well as her understanding of health law and legal background, to help health care organizations create better health outcomes and modernize the health care industry.

A trusted counselor, Rachel provides advice to clients on a wide range of health care matters, with an emphasis on strategy, regulatory, and compliance issues. Clients value her in-depth knowledge of federal health care policy and regulatory issues, her strategic and creative thinking, and her ability to navigate them through the complex health care regulatory system in order to advance the coverage of new health care technologies. Rachel has a particular interest in new offerings such as telehealth, digital health, artificial intelligence, and femtech.

In addition to guiding health care and life sciences clients through complex health regulatory and compliance challenges, Rachel partners with employers to proactively improve accessibility through compliance with the Americans with Disabilities Act (ADA). Employers view her as a business ally who understands their unique needs, anticipates problems, and provides effective solutions.

Before joining Epstein Becker Green, Rachel served as Senior Health Advisor to Steny H. Hoyer during his tenure as the Majority Leader of the U.S. House of Representatives. Congressman Hoyer shepherded both the ADA and the ADA Amendments Act through Congress as the House sponsor of the ADA. Rachel served as the lead advisor in his office, partnering with industry leaders and disability advocates in connection with the implementation of the ADA by federal agencies and the courts in the decades since the law’s passage. She also played a key role in collaborating with and mediating between House committees of jurisdiction, House and Senate committees of jurisdiction, and Congress and the White House to ensure the passage of such crucial legislation as the No Surprises Act and the Inflation Reduction Act, as well as bills to address the COVID-19 pandemic, the mental health crisis, and the opioid epidemic.

In addition to her time in Majority Leader Hoyer's office, Rachel served as a Congressional Affairs Intern in the Office of Legislation at the U.S. Food and Drug Administration (FDA), where she supported the work of addressing congressional inquiries to the FDA. She also served as a Legislative Aide to U.S. Senator Barbara A. Mikulski of Maryland. Earlier in her career, Rachel was a Judicial Intern for the Honorable Charles J. Peters of the Baltimore City Circuit Court and the Honorable Ellen L. Hollander of the U.S. District Court for the District of Maryland.

Philo D. Hall

Member of the Firm
Epstein Becker Green

Drawing upon nearly 12 years of experience in a series of federal government health policy positions, attorney Philo Hall brings insight into the legal, policy, budgetary, and political factors influencing federal agency decision-making.

Philo’s experience includes:

  • Counseling health plans, providers, manufacturers, and related investors on complex reimbursement issues arising under Medicare and Medicaid law and policies
  • Advising health systems, health plans, and providers on the legal and regulatory matters arising under the transition to value-based care reimbursement and accountable care
  • Providing interpretive and practical advice regarding the oversight and compliance requirements unique to Medicare Advantage and Medicare Prescription Drug plans, as well as responding to related federal sanctions
  • Advising health care providers, health-related companies, financial institutions, and investors of health care industry trends and relevant federal and state public policy developments
  • Aiding health care providers, health plans, and related companies in the development and operation of out-of-network billing arrangements to assure compliance with federal and state laws
  • Advising public and private clients in the development of legislative and regulatory advocacy strategies involving government health programs, including assisting with the development and implementation of public stakeholder engagement efforts
  • Counseling clients and conducting regulatory due diligence in connection with various strategic transactions, such as  mergers, acquisitions, and affiliations

Before joining Epstein Becker Green, Philo served as Counselor to Michael O. Leavitt, Secretary of the U.S. Department of Health and Human Services. In that role, Philo directly advised the Secretary and the White House on a diverse portfolio of issues facing the Centers for Medicare & Medicaid Services, the Substance Abuse and Mental Health Services Administration (also known as “SAMHSA”), the Office of Civil Rights, the Administration for Children and Families, the Centers for Disease Control, and the Office of the Assistant Secretary for Health.

Philo earlier served as Associate Director for Health on the staff of the White House Domestic Policy Council, advising the President of the United States and senior staff on emerging health care issues, legislation, and regulatory matters. This position involved overseeing federal agency implementation of the administration’s health care priorities, with a particular focus on behavioral health, including managing the formation and operation of the President’s New Freedom Commission on Mental Health. Philo also served on the professional staff of the U.S. Senate Committee on Health, Education, Labor, and Pensions, under Chairman James M. Jeffords (R-VT), where he developed legislation on Medicare provider reimbursement, commercial insurance regulation, and health information privacy.

During law school, Philo was a judicial intern for the Hon. Richard J. Leon of the U.S. District Court for the District of Columbia; a member of the Journal of Contemporary Health Law and Policy; and a student attorney at Columbus Community Legal Services, representing low-income elderly clients in the District of Columbia.

David McNitt

Partner
The National Group

David McNitt is a Partner of The National Group and a non-lawyer Partner of the affiliated firm, the Oldaker Group. Mr. McNitt’s practice focuses on federal regulatory and legislative matters across a diverse portfolio of issues including health care policy, the federal budget, transportation policy, environmental policy and energy policy. He has represented the federal interests of hospital systems, medical device companies, healthcare associations, technology companies, universities and non-profits before Congress and federal agencies. Mr. McNitt joined The National Group in 2005, where he matched clients’ internal funding priorities with federal resources, and secured substantial federal appropriations for projects of regional and national importance. In 2006, Mr. McNitt joined the Oldaker firm, where he focuses on healthcare policy. He has worked extensively on issues relating to the Patient Protection and Affordable Care Act, extramural federal health care research and programmatic funding and the Food and Drug Administration Safety and Innovation Act among other legislative and regulatory healthcare matters. In addition to his professional policy and advocacy work, Mr. McNitt has worked on national and state-wide political races, including a presidential campaign. He has advised political action committees (PACs) on compliance issues, and managed federal and state reporting requirements for House, Senate and state candidates.Mr. McNitt grew up in southeastern Pennsylvania, and is an avid Philadelphia sports fan. He left the Keystone state for college and graduated with honors from Tulane University with a B.A. in Political Science and German. He also studied political science at St. Andrew's University in Scotland.

Christine Burke Worthen

Member of the Firm
Epstein Becker Green

Health care providers, payers, digital health companies, and investors call on attorney Christine Burke Worthen for legal and strategic advice as they navigate complex regulatory and business challenges in the continuously evolving health care delivery and reimbursement landscape.

Her practical guidance enables clients across the health care ecosystem—health systems, hospitals, physician practices, digital health companies, behavioral health providers, third-party administrators, health plans, and investors—to implement both short- and long-term strategies that align with their organizational goals.

Christine possesses a wealth of experience working on matters concerning Medicare reimbursement, Medicare Advantage, participation in CMS Innovation Center payment models, managed Medicaid, managed care contract negotiations, and value-based payment arrangements with commercial payers, self-insured employers, and Medicare Advantage plans. She provides counsel on the regulatory, operational, and financial considerations necessary for maneuvering through the changing payment environment, including various forms of risk-based payment models, price transparency, revenue cycle and payment integrity, clinically integrated network development and value-based enterprise models, risk adjustment, and provider compensation arrangements.

New market entrants rely on Christine for assistance in establishing compliant care delivery models across markets, whether through traditional brick-and-mortar models, home-based models, or virtual models of care, and transforming innovative ideas into reimbursable strategies. Investors rely on Christine for assistance with evaluating the opportunities for optimizing payer contracts and network relationships to achieve sustainable financial performance and regulatory due diligence in transactions.

Christine also advises on other areas of concern for payers, investors, and providers, such as health care fraud and abuse compliance, HIPAA/Part 2 compliance, licensing, mental health parity compliance, and payer disputes.

Beyond her health care practice, Christine provides ERISA counsel to employers regarding their defined benefit and defined contribution retirement plans, as well as self-insured and fully insured welfare benefits plans. She has represented clients in government audits conducted by the IRS and the U.S. Department of Labor.

Before joining Epstein Becker Green, Christine was a partner in the health care practice of a national law firm. She previously served as Vice President and Senior Counsel at a health system in Maine. Earlier in her career, Christine was a partner and chair of the Healthcare Services Practice Group in a regional law firm's Portland (Maine) and Boston offices.